J. Rossouw, G. Anderson, and R. Prentice, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, vol.288, pp.321-354, 2002.

V. Beral, Breast cancer and hormone-replacement therapy: the Million Women Study, The Lancet, vol.362, issue.9392, pp.419-446, 2003.
DOI : 10.1016/S0140-6736(03)14596-5

V. Ringa, N. Varnoux, S. Piault, and G. Breart, Hormone therapy use among postmenopausal French women before the publication of the Women???s Health Initiative Study: duration of use and factors associated with discontinuation, Fertility and Sterility, vol.83, issue.6, pp.1771-1780, 2005.
DOI : 10.1016/j.fertnstert.2004.12.040

A. Fournier, F. Berrino, and F. Clavel-chapelon, Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study, Breast Cancer Research and Treatment, vol.95, issue.1, pp.103-114, 2008.
DOI : 10.1007/s10549-007-9523-x

URL : https://hal.archives-ouvertes.fr/inserm-00201813

M. Canonico, G. Plu-bureau, G. Lowe, and P. Scarabin, Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis, BMJ, vol.336, issue.7655, pp.1227-1258, 2008.
DOI : 10.1136/bmj.39555.441944.BE

URL : https://hal.archives-ouvertes.fr/inserm-01142884

A. Franc-xaise-de-la-s-ecurit-e, Sanitaire des Produits de Sant e Mise au point sur le traitement hormonal substitutif de la m enopause Available from URL

D. Buist, K. Newton, D. Miglioretti, K. Beverly, M. Connelly et al., Hormone Therapy Prescribing Patterns in the United States, Obstetrics & Gynecology, vol.104, issue.5, Part 1, pp.1042-50, 2004.
DOI : 10.1097/01.AOG.0000143826.38439.af

B. Ettinger, D. Grady, A. Tosteson, A. Pressman, and J. Macer, Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy, Obstetrics & Gynecology, vol.102, issue.6, pp.1225-1257, 2003.
DOI : 10.1016/j.obstetgynecol.2003.08.007

C. Heitmann, E. Greiser, and M. Doren, The impact of the Women??s Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany, Menopause, vol.12, issue.4, pp.405-416, 2005.
DOI : 10.1097/01.GME.0000153890.77135.00

F. Parazzini, Trends of determinants of hormone therapy use in Italian women attending menopause clinics, Menopause, vol.15, pp.164-70, 1997.

M. Goldberg, J. Chastang, A. Leclerc, M. Zins, S. Bonenfant et al., Socioeconomic, Demographic, Occupational, and Health Factors Associated with Participation in a Long-term Epidemiologic Survey: A Prospective Study of the French GAZEL Cohort and Its Target Population, American Journal of Epidemiology, vol.154, issue.4, pp.373-84, 2001.
DOI : 10.1093/aje/154.4.373

A. Fauconnier, V. Ringa, D. Delanoe, B. Falissard, and G. Breart, Use of hormone replacement therapy: women???s representations of menopause and beauty care practices, Maturitas, vol.35, issue.3, pp.215-243, 2000.
DOI : 10.1016/S0378-5122(00)00130-4

A. Fournier, F. Berrino, E. Riboli, V. Avenel, and F. Clavel-chapelon, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, International Journal of Cancer, vol.158, issue.3, pp.448-54, 2005.
DOI : 10.1002/ijc.20710

URL : https://hal.archives-ouvertes.fr/inserm-00129104

J. Ness, W. Aronow, E. Newkirk, and D. Mcdanel, Use of Hormone Replacement Therapy by Postmenopausal Women After Publication of the Women's Health Initiative Trial, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.60, issue.4, pp.460-462, 2005.
DOI : 10.1093/gerona/60.4.460

B. Lawton, S. Rose, D. Mcleod, and A. Dowell, Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users, BMJ, vol.327, issue.7419, pp.845-851, 2003.
DOI : 10.1136/bmj.327.7419.845

U. Menon, M. Burnell, A. Sharma, A. Gentry-maharaj, L. Fraser et al., Decline in use of hormone therapy among postmenopausal women in the United Kingdom, Menopause, vol.14, issue.3, pp.462-469, 2007.
DOI : 10.1097/01.gme.0000243569.70946.9d

J. Haas, C. Kaplan, E. Gerstenberger, and K. Kerlikowske, Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results, Annals of Internal Medicine, vol.140, issue.3, pp.184-192, 2004.
DOI : 10.7326/0003-4819-140-3-200402030-00009

A. Maclennan, A. Taylor, and D. Wilson, Hormone therapy use after the Women's Health Initiative, Climacteric, vol.2, issue.2, pp.138-180, 2004.
DOI : 10.1097/01.AOG.0000114986.14806.37

A. Morabia and M. Costanza, Recent reversal of trends in hormone therapy use in a European population, Menopause, vol.13, issue.1, pp.111-116, 2006.
DOI : 10.1097/01.gme.0000172595.68648.16

I. Helenius, D. Korenstein, and E. Halm, Changing use of hormone therapy among minority women since the Women's Health Initiative, Menopause, vol.14, issue.2, pp.216-238, 2007.
DOI : 10.1097/01.gme.0000233169.65045.b1

C. Barber, K. Margolis, R. Luepker, and D. Arnett, The Impact of the Women's Health Initiative on Discontinuation of Postmenopausal Hormone Therapy: The Minnesota Heart Survey (2000???2002), Journal of Women's Health, vol.13, issue.9, pp.975-85, 2000.
DOI : 10.1089/jwh.2004.13.975

S. Rolnick, R. Kopher, T. Defor, and M. Kelley, Hormone use and patient concerns after the findings of the Women??s Health Initiative, Menopause, vol.12, issue.4, pp.399-404, 2005.
DOI : 10.1097/01.GME.0000148644.55486.36

J. Blumel, C. Castelo-branco, P. Chedraui, L. Binfa, B. Dowlani et al., Patients' and clinicians' attitudes after the Women's Health Initiative study, Menopause, vol.11, issue.1, pp.57-61, 2004.
DOI : 10.1097/01.GME.0000075503.60230.61

H. Ekstrom, Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it, Maturitas, vol.52, issue.2, pp.154-64, 2005.
DOI : 10.1016/j.maturitas.2005.01.010

E. Hing and K. Brett, Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001.

A. Hersh, M. Stefanick, and R. Stafford, National Use of Postmenopausal Hormone Therapy, JAMA, vol.291, issue.1, pp.47-53, 2004.
DOI : 10.1001/jama.291.1.47

P. Austin, M. Mamdani, K. Tu, and L. Jaakkimainen, Prescriptions for Estrogen Replacement Therapy in Ontario Before and After Publication of the Women's Health Initiative Study, JAMA: The Journal of the American Medical Association, vol.289, issue.24, pp.3241-3243, 2003.
DOI : 10.1001/jama.289.24.3241

K. Leung, M. Ling, and G. Tang, Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial, Maturitas, vol.52, issue.3-4, pp.277-85, 2005.
DOI : 10.1016/j.maturitas.2005.04.008

. De-jong-van-den, L. Berg, A. Faber, P. Van-den-berg, and . Hrt, HRT use in 2001 and 2004 in The Netherlands???A world of difference, Maturitas, vol.54, issue.2, pp.193-200, 2001.
DOI : 10.1016/j.maturitas.2005.10.010

A. Gayet-ageron, N. Amamra, V. Ringa, V. Tainturier, C. Berr et al., Estimated numbers of postmenopausal women treated by hormone therapy in France, Maturitas, vol.52, issue.3-4, pp.296-305, 2005.
DOI : 10.1016/j.maturitas.2005.05.002

URL : https://hal.archives-ouvertes.fr/inserm-00151132

S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington et al., Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women, JAMA, vol.280, issue.7, pp.605-618, 1998.
DOI : 10.1001/jama.280.7.605

V. Meyer, The Medicalization of Menopause: Critique and Consequences, International Journal of Health Services, vol.356, issue.4, pp.769-92, 2001.
DOI : 10.1056/NEJM199307083290207

M. Hoffmann, M. Hammar, K. Kjellgren, L. Lindh-astrand, and J. Brynhildsen, Changes in women's attitudes towards and use of hormone therapy after HERS and WHI, Maturitas, vol.52, issue.1, pp.11-18, 2005.
DOI : 10.1016/j.maturitas.2005.06.003